Oral squamous cell carcinoma radiation therapy for dogs and cats — AARADONC Palm Beach Florida
Oral SCC Radiation Therapy · Dogs & Cats · Florida

Oral squamous cell
carcinoma radiation
therapy — Florida.

Oral SCC is the most common oral malignancy in cats and a frequent diagnosis in dogs. Radiation therapy — alone or combined with surgery — achieves local control for dog oral SCC, and provides meaningful palliative relief for cats.

Request a ConsultationSee Treatment Options ↓
Board Certified Radiation Oncologist on site
Palm Beach County, FL
Same-week consultations
#1
Most common oral malignancy in cats
50–70%
Local control rate with CFRT for rostral mandibular SCC in dogs
4–20
Sessions — palliative or definitive based on goals
Same day
Home after every session — outpatient treatment

“The only center 100% dedicated to Radiation Oncology in Florida”

Understanding Oral SCC in Dogs and Cats

Oral SCC in dogs vs. cats —
two very different diseases.

Oral squamous cell carcinoma behaves differently in dogs and cats — in prognosis, location, and response to treatment. Understanding this distinction is essential before setting treatment expectations. Dr. DiBernardi provides an honest, individualized assessment for every patient presented with oral SCC.

In dogs, gingival and mandibular SCC — particularly rostral (front) tumors — are locally invasive but relatively slow to metastasize. Surgery combined with radiation achieves durable local control for many dogs. In cats, oral SCC is one of the most aggressive cancers in veterinary oncology: typically diagnosed late, deeply invasive, and with limited response to most treatment modalities.

The role of radiation in dogs with oral SCC

For dogs, radiation is used adjuvantly after surgery when margins are incomplete, or as the primary treatment when complete resection is not feasible. Definitive CFRT for gingival and mandibular SCC achieves local control in 50–70% of dogs with rostral tumors, with good quality of life throughout. Tonsil SCC carries a significantly worse prognosis and is typically approached palliatively.

Location matters significantly in canine oral SCC. Rostral mandibular tumors respond better to radiation than caudal, tonsil, or sublingual lesions. CT imaging before treatment planning is essential to determine invasion depth, lymph node status, and the feasibility of surgical or combined approaches.

The role of radiation in cats with oral SCC

Feline oral SCC is diagnosed most commonly as a sublingual or gingival mass causing drooling, difficulty eating, and facial swelling. The prognosis is poor regardless of treatment — most cats survive 2–4 months even with aggressive therapy. Palliative radiation (4–6 sessions) can provide meaningful pain control, reduce tumor burden, and improve quality of life. An honest conversation about goals of care is central to every feline oral SCC consultation at AARADONC.

At AARADONC, Dr. Lisa DiBernardi personally reviews every oral SCC case and provides a clear, honest prognosis before any treatment begins. Treatment goals — curative intent vs. quality-of-life focus — are established together with the pet owner at the outset.
50–70%
Local control with CFRT for rostral mandibular SCC in dogs
4–6
Palliative sessions for cats — pain control and QoL
Same day
Home after every session — outpatient treatment
Treatment at AARADONC

Honest goals.
Precise treatment.

Every oral SCC case at AARADONC starts with a complete specialist review — CT imaging, staging, and a frank conversation about goals of care. Dr. DiBernardi designs every plan personally, with treatment intent established clearly from the start.

Varian TrueBeam® + IGRT. Cone Beam CT before every session confirms tumor and patient positioning — especially important in the oral cavity, where adjacent structures (mandible, palate, tongue, salivary glands) require precise dose management.

Definitive CFRT for dogs with curative intent. 16–20 fractionated sessions deliver precise cumulative doses to the oral tumor volume — used as primary treatment or adjuvant after surgery with incomplete margins.

Palliative radiation for cats and select dogs. 4–6 session hypofractionated protocols prioritize pain control, tumor reduction, and quality of life over total dose — the appropriate approach for feline oral SCC and advanced canine disease.

Learn more about our protocols →
Protocol Options

Protocol chosen by species, location, and goals.

Dogs — Curative Intent
CFRT
16–20 sessions
Adjuvant or primary · daily Mon–Fri · outpatient
Learn more →
Cats & Palliative Cases
Palliative Radiation
4–6 sessions
Pain relief · QoL focus · outpatient
Learn more →
Common Questions

What pet owners
ask us most.

Oral squamous cell carcinoma (SCC) is a malignant tumor arising from the epithelial lining of the mouth — gums, tongue, tonsils, or palate. It is the most common oral malignancy in cats and one of the most frequent in dogs. Behavior differs significantly by species and location: in dogs, gingival SCC is often locally invasive but slow to metastasize, while feline oral SCC is highly aggressive with rapid local invasion and limited response to most treatments.
For Pet Owners
Get a specialist review.
Same-day response.

Dr. DiBernardi personally reviews every case. Tell us about your pet and we'll respond the same day with a clear, honest recommendation.

Request a Consultation
For Veterinarians
Refer a patient with
oral SCC.

Submit a referral and receive same-day acknowledgment. We coordinate directly with your practice throughout treatment and provide full written reports.

Referral Information →